Medical Research Council of Ireland annual report for the year ended 31st December 1982

Hdl Handle:
http://hdl.handle.net/10147/240931
Title:
Medical Research Council of Ireland annual report for the year ended 31st December 1982
Authors:
Medical Research Council of Ireland
Publisher:
Medical Research Council of Ireland
Issue Date:
31-Dec-1982
URI:
http://hdl.handle.net/10147/240931
Item Type:
Report
Language:
en
Description:
As in previous years and as is the practice in other countries, the Council has supported medical research using three different funding mechanisms; grants to individual investigators for single projects, support for research units to undertake programmes of research, support for the Medical Research Council's own laboratory located in Trinity College, Dublin. A total of 55 new applications were received for project grants in the year under review. Of these 13 were not recommended for funding for a variety of reasons such as lack of facilities, faulty design etc. The remaining 42 were highly recommended and, of these, 27 were funded but 15 were not funded. The latter, though highly recommended were not granted due to insufficient funds being available. Furthermore, in the majority of cases where funding was granted, the sums granted were substantially less than requested. The scheme for supporting research units is now well under way with three of the units in the third year while one, that on brucellosis, has finished. The Alcohol Research Unit has a broad remit, varying from basic laboratory investigations to studying mental health problems associated with alcohol addiction. The Coeliac Disease Research Unit also continues its studies of a disease which is known to have a particularly high prevalence in this country. The problem of high blood pressure, surely a major cause of medical concern in developed countries, is being investigated both at a laboratory and clinical level by the Hypertension Research Unit. rt was possible to start funding a programme of research on Lung Fibrosis under the direction of Professor M. Fitzgerald in St. Vincent's Hospital to replace the Brucellosis Unit. In addition, support was made available for a unit on Hospital infection under the direction of Professors Arbuthnott and Keane. Additional programmes approved but not funded were for Drugs in the Elderly and Peri natal Mortality and Morbidity. The personnel of the Medical Research Council Laboratories continue their studies into the development of a drug which could be used in combatting cancer. They are also maintaining an active role in the development of new anti-leprosy drugs, an area where they have already gained international recognition with the synthesis of clofazimine some years ago. The Council's ability to meet its financial commitments in these areas has disimproved over the year under review. This problem, coupled with our historically low funding base, has put great constraints upon all of our investigators. In practical terms, this has resulted in the Council being unable to fund 36% of projects that were highly recommended after peer review. Furthermore, two approved units could not be funded. Clearly, much important research is left undone and, when funding is reduced, investigators must continue to carry out their studies in increasingly difficult circumstances. In a break with tradition, the Council held a press conference in its premises on the occasion of the presentation of the annual report for 1981 to the Minister for Health, Dr. Michael Woods T.D. The conference was well attended by representatives of the press who played an active role in the proceedings. Subsequent to the press conference a useful exchange of ideas took place between the members of the Council and the Minister
Keywords:
MEDICAL RESEARCH; IRELAND

Full metadata record

DC FieldValue Language
dc.contributor.authorMedical Research Council of Irelanden_GB
dc.date.accessioned2012-08-31T21:01:22Z-
dc.date.available2012-08-31T21:01:22Z-
dc.date.issued1982-12-31-
dc.identifier.urihttp://hdl.handle.net/10147/240931-
dc.descriptionAs in previous years and as is the practice in other countries, the Council has supported medical research using three different funding mechanisms; grants to individual investigators for single projects, support for research units to undertake programmes of research, support for the Medical Research Council's own laboratory located in Trinity College, Dublin. A total of 55 new applications were received for project grants in the year under review. Of these 13 were not recommended for funding for a variety of reasons such as lack of facilities, faulty design etc. The remaining 42 were highly recommended and, of these, 27 were funded but 15 were not funded. The latter, though highly recommended were not granted due to insufficient funds being available. Furthermore, in the majority of cases where funding was granted, the sums granted were substantially less than requested. The scheme for supporting research units is now well under way with three of the units in the third year while one, that on brucellosis, has finished. The Alcohol Research Unit has a broad remit, varying from basic laboratory investigations to studying mental health problems associated with alcohol addiction. The Coeliac Disease Research Unit also continues its studies of a disease which is known to have a particularly high prevalence in this country. The problem of high blood pressure, surely a major cause of medical concern in developed countries, is being investigated both at a laboratory and clinical level by the Hypertension Research Unit. rt was possible to start funding a programme of research on Lung Fibrosis under the direction of Professor M. Fitzgerald in St. Vincent's Hospital to replace the Brucellosis Unit. In addition, support was made available for a unit on Hospital infection under the direction of Professors Arbuthnott and Keane. Additional programmes approved but not funded were for Drugs in the Elderly and Peri natal Mortality and Morbidity. The personnel of the Medical Research Council Laboratories continue their studies into the development of a drug which could be used in combatting cancer. They are also maintaining an active role in the development of new anti-leprosy drugs, an area where they have already gained international recognition with the synthesis of clofazimine some years ago. The Council's ability to meet its financial commitments in these areas has disimproved over the year under review. This problem, coupled with our historically low funding base, has put great constraints upon all of our investigators. In practical terms, this has resulted in the Council being unable to fund 36% of projects that were highly recommended after peer review. Furthermore, two approved units could not be funded. Clearly, much important research is left undone and, when funding is reduced, investigators must continue to carry out their studies in increasingly difficult circumstances. In a break with tradition, the Council held a press conference in its premises on the occasion of the presentation of the annual report for 1981 to the Minister for Health, Dr. Michael Woods T.D. The conference was well attended by representatives of the press who played an active role in the proceedings. Subsequent to the press conference a useful exchange of ideas took place between the members of the Council and the Ministeren_GB
dc.language.isoenen
dc.publisherMedical Research Council of Irelanden_GB
dc.subjectMEDICAL RESEARCHen_GB
dc.subjectIRELANDen_GB
dc.titleMedical Research Council of Ireland annual report for the year ended 31st December 1982en_GB
dc.typeReporten
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.